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ABSTRACT
The availability of inexpensive synthetic DNA (oligonucleotides) has allowed for the synthesis
of longer, gene-length constructs of DNA. However, a critical barrier to making this technology
a low-cost and high-throughput process has been due to the rate at which errors pervade the final
product. The current state of the error reduction technology includes three different categories:
error filtration, error correction, and error prevention. My research is a joint project as well as an
addendum to the work done by Research Scientist Dr. Peter Carr and current MIT Department of
Biological Engineering Masters Student Jason Park (MIT '05) who have been working on
research in gene synthesis error correction over the past several years. I have been working very
closely with both Dr. Carr and Jason Park on this research for the past two years. We have a
publication we're about to submit in regards to optimizations of gene synthesis and a significant
portion of my thesis deals with work done for the upcoming publication. My work includes
optimizing the synthesis of large gene constructs, the synthesis of new hyper-thermophilic MutS
proteins, characterizing these proteins using instruments such as the circular dichroism
spectrophotometer and the Evotec MF20, as well as perfecting old error correction protocols
while designing several new ones.
Thesis Supervisor: Joseph Jacobson
Title: Associate Professor of Media Arts and Sciences and Mechanical Engineering
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I. Introduction
Basics of Gene Fabrication
The isolation and manipulation of genes and other large DNA molecules plays a critical
role in many areas of molecular biology research. Unfortunately the current expense, time and
labor of generating and modifying such constructs is substantial. An alternative is direct
synthesis of a desired gene. But while the cost of synthetic oligonucleotides has approached the
point (-$0.10 per base) where most laboratories simply purchase these, synthetic genes are still
expensive, with typical costs of $1 to $2 per base (i.e. $1000 to $2000 per 1 kilobase gene) and a
turn around time of 2-4 weeks. Regrettably such expenditures greatly limit the number and type
of experiments which can be carried out in such areas as the study of gene pathways and de novo
protein design, and all but preclude the construction of large gene libraries without extraordinary
cost.
We set out to develop a technology platform that would make fast, economical high
throughput gene synthesis a reality. Most needed at the inception of this project was a completely
general means of DNA error reduction that could easily be implemented into a gene synthesis
process. The error rates of current approaches add significantly to the effort expended towards
quality control, and make direct synthesis of large DNA constructs especially troublesome. Thus
to fabricate a desired piece of DNA larger than a few kilobases, one must typically first employ
multiple costly and time-consuming cycles of assembly, cloning, and sequencing of smaller
fragments.
The ultimate goal of gene fabrication research is to be able to have readily available and
affordable methods and technologies that allow researchers and scientists to fabricate large DNA
molecules. Current technologies are only effective for making single genes and can be slow and
costly. As genetic engineering moves from a focus on single genes to designing complete
biochemical pathways, genetic networks, and more complex systems, lower-cost, higher-
throughput gene fabrication technology will become increasingly important. However, reaching
this goal in genetic engineering is highly unlikely and even impossible without better error
correction/reduction protocols.
Nature provides mechanisms and methods of synthesizing DNA with error rates ranging
from error in 108 base pairs to 1 error in 1010° base pairs. However there are no in vitro error
correction methods for DNA synthesis with even remotely close fidelity. The lowest published
error rates thus far have been 1 error in 105 base pairs. So there is still much improvement that
can be made to current error correction protocols.
There are many applications of good gene fabrication technology ranging from synthesis
of genes with novel functionalities that do not even exist in nature to synthesis of multiple genes
at once. Also, the ability to synthesize a gene de novo eliminates the need to obtain an organism
from its natural habitat in order to study one of its genes.
The Jacobson group of the MIT Media Lab has made some progress in the area of error
correction by employing a DNA mismatch-binding protein, MutS (from Thermus aquaticus) to
remove failure products from synthetic genes (Carr et al, 2004). I have been working with the
Jacobson group for the past two years on optimizing the synthesis of large gene constructs, the
synthesis of new hyper-thermophilic MutS proteins, characterizing these proteins using the
circular dichroism spectrophotometer and the Evotec MF20, as well as designing more error
correction protocols.
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Current Methods of Gene Fabrication
Currently there are several protocols for in vitro synthesis of DNA in gene fabrication.
The most prominent among these - and the protocol that we use - involves the use of the
Polymerase Chain Reaction (PCR) (Park, 2005). The components of the reaction include:
thermostable DNA polymerase, dNTPs, PCR buffer (including salts), a pool of oligonucleotides
that together make up the entire sequence of the target DNA, and sometimes, oligonucleotide
primers that define the ends of the target DNA (Park, 2005). The oligonucleotides in the starting
pool are built up into longer constructs through successive rounds of PCR. The full-length
constructs are amplified exponentially as in traditional PCR by the end oligonucleotide primers.
There are several methods to perform PCR for gene fabrication. For example, gene
synthesis can be performed in a one-step process or two-step process (Park, 2005). In a one-step
process, both the oligonucleotide pool and a high concentration of the end primers are included
in the PCR. Thus, there is at once the linear build-up of the full-length product from the
oligonucleotide pool and the end primers as well as exponential amplification of the full-length
product once the first copy is synthesized. Though in general the one-step process requires much
more fine-tuning of parameters than the two-step process and is difficult to do for longer gene
products, it has the advantage of being quicker and reducing the amount of sample handling. For
one thing, reducing the number of sample handling steps will be increasingly important as error
correction protocols are ported from the lab bench to automatable microfluidic devices. In a
two-step process, the first PCR assembles the oligonucleotide in the oligonucleotide pool
together into the full-length product at some low frequency. The second PCR includes some of
the first PCR product and adds primers that correspond to the ends of the full-length product
sequence. This serves to exponentially amplify the full-length product sequence like a traditional
PCR.
Optimization of Gene Fabrication
When a small piece of single-stranded DNA, (an oligonucleotide, "oligo") is desired, the
process for obtaining it is as simple as filling out an online order form, waiting 1-2 days, and
paying perhaps 10-20 U.S. dollars (depending on the oligo length). It is notable that roughly half
of both the time and cost to receive a single oligo can be for shipping, not producing the
molecules. This was not true as recently as 5-10 years ago, but costs have come down
dramatically. A similar metric should be possible for obtaining pieces of DNA the lengths of
single genes or longer: no more than a few days and a few tens of dollars per gene, producing
virtually any sequence defined by the user. When this benchmark is achieved, many basic DNA
manipulations now performed in the laboratory (for example mutagenesis, cloning, purifications)
will often be replaced by simply ordering the exact DNA species desired.
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Figure 1. Schematic for gene synthesis by
Polymerase Construction and Amplification.
A pool of oligonucleotides is synthesized,
representing the complete sequence of a
desired gene. During ultiple rounds of oligo
annealing and extension by DNA
polymerase, each oligo acts as both primer
and template, generating successively longer
DNA assemblies, until the full length gene is
produced. The pool of heterogeneous DNA
products is enriched for the full length
species by amplification via polymerase
chain reaction (PCR, final step).
Gene synthesis companies have
proliferated in the past five years, indicative of
strong demand for synthetic genes. These
companies have made substantial progress in
reducing the costs and times involved in
production, to where one may now expect to
wait two to four weeks for a gene, and pay
$1.00-$1.60 US dollars per base pair (bp),
averaging roughly $1300 for 1000 bp. "Do it
yourself' gene synthesis at the research bench
is also feasible, and increasing in popularity
(see Figure 1 for the most common technique).
For a lab already equipped with conventional
molecular biology equipment, the principal
costs are the oligos-both strands of a 1000 bp
gene cost $0.16-$0.20 per base of oligos (list
price Invitrogen, IDT, if synthesized in high
throughput format) i.e. $300 or more, a modest
amount of labor, cloning reagents, and
sequencing services. Figure 1 illustrates the
most commonly employed general approach
for gene synthesis, though many variants exist.
Strong demand for easy access to genes
of interest is also evidenced by the emergence
of large clone collections, both commercial
(e.g. Invitrogen Ultimate ORF Clones,
currently $765 each, or the OriGene TrueClone
Collection, $195-$995 per clone) and nonprofit
(e.g. the Mammalian Genome Collection,
currently $89 per clone). These collections
begin to address a tremendous need by making
commercially available known genes found in
living systems. However, synthetic genes have
the capacity to reach far beyond these
collections by providing the flexibility of user
customization. Furthermore, low cost synthetic DNA on-demand would obviate the need for
large centralized physical archives.
For a single gene of interest, the above costs fit well within many research budgets. But
there are several research applications which would benefit from large sets of genes, such as
studying interactions between every member of a particular functional class, many mutants of a
single gene (for example, alanine scanning mutagenesis), a protein design project which requires
many revisions of a gene, or labeling all the genes from a single genome (say, 4,000 to 30,000
genes) with an antigenic peptide tag or fluorescent protein for detection. If the synthetic capacity
for generating such large sets of genes were available at low cost, it would be heavily utilized.
In addition to dramatically accelerating existing areas of experimentation, high-
throughput DNA synthesis will enable new kinds of research and design projects. Already, those
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working in the field dubbed Synthetic Biology are designing increasingly larger and more
complex artificial genetic systems, built mostly from modified genes found in nature (Elowitz,
2000). Notable examples of completely non-biological DNA designs are beginning to emerge as
well (Shih, 2004). The DNA constructs required for some proposed projects are so large that
conventional gene synthesis becomes prohibitively expensive. These include complex in vitro
genetics systems such as that proposed by Church and colleagues (Tian, 2004). Other groups are
pursuing the direct synthesis of entire simple genomes (Smith, 2003). Such projects aim both to
test hypotheses on the fundamental requirements for life, and to generate organisms that have
been dramatically re-engineered for new purposes, such as waste processing, energy production,
and complex syntheses of useful compounds.
Basic impediments to drastically reducing the time and costs of gene synthesis include 1)
costs of raw materials, especially oligonucleotides or their precursors and enzymes; 2) the
extensive sample handling required; 3) quality control (particularly DNA sequencing) mandated
by the intrinsic error rates of the synthesis process (both of oligonucleotide synthesis and the
assembly of oligonucleotides into genes).
.. .. . A--_
100l 1WODOA
80 1I0,000
- 60 1000
052_1 U~~~~~~
o. 40 \ 1002)
20 0 10
20~ 0 1 0
U' ___ .. _ 1 - - - - - - - -
length of DNA target (bp) length of DNA target (bp)
Figure 2. Influence of error rates on de novo DNA synthesis. A. For a given
error rate, the purity of gene synthesis products (yield of error-free clones)
decreases exponentially with the length of the product synthesized. Error
rates shown are 1 in 600 bp (blue, lower curve) typical of conventional gene
synthesis approaches, 1 in 1400 bp} (red, middle curve), and 1 in 10,000 bp
(yellow, upper curve) achieved with our methods described below. B. The
number of clones which must be sequenced to have a high (95%)
probability of obtaining at least one which is error-free. The same three
error rates as in (A) are indicated (lower, yellow curve is 1/10,000, etc)
To reduce materials costs, oligonucleotide microarrays show tremendous promise. In
such arrays, large numbers of distinct oligos are synthesized in parallel, in situ-directly on a
surface, typically a glass microscope slide. With spot sizes on the order of one hundred microns
or less, these arrays can contain tens of thousands or hundreds of thousands of specific
sequences. With the cost of an array ranging from a few hundred to a few thousand dollars,
individual oligos on the array can effectively cost between lx10 5 and lx10-3 dollars per base
pair-orders of magnitude less than conventionally synthesized oligos. Thus, the contribution of
the cost of oligonucleotides to the overall cost of gene synthesis could be reduced to an almost
insignificant amount. Progress in taking advantage of microarrays for gene synthesis has
6
I
recently been reported, cleaving oligos from the array surface, amplifying them via polymerase
chain reaction (PCR) and assembling them into genes in test tubes.
The other key to the above challenges lies with controlling the errors implicit in gene
synthesis. These errors begin with mistakes occurring during synthesis of the oligonucleotide
precursors, some of which are propagated into the final product. Additional errors can occur
during assembly and amplification (Figure 1), such as those introduced by DNA polymerase.
Even after a synthetic gene is cloned, errors in biological replication can occur, though these
rates are expected to be comparatively low relative to the other sources of error. The error rates
of biological replication in fact set the standard to which gene synthesis technology should aspire
to.
The consequences of errors in current gene synthesis approaches can be dramatic,
especially when one desires genes greater than 1 kb in length. Figure 2A demonstrates the
expected purity of a synthetic gene preparation with rates ranging from 1 error in 600 bp (fairly
standard in our gene syntheses without any special error reduction, but equal or better than most
reports in the literature) to 1 in 10,000 bp. For large constructs, at a conventional error rate of
1/600 very little of the mixture contains the correct product. A typical do-it-yourself user must
choose a number of clones (colonies) to grow, isolate DNA from, and sequence-the number of
isolates one must characterize rapidly increases beyond a practical range for greater than 1 kb
(see Figure 2B).
Recent reports from four separate teams led by Venter, Cello, Church, and Santi have
demonstrated excellent advances in the capacity to fabricate large molecules of DNA from
oligonucleotides, with products 5.4, 7.5, 15 and 32 kb in length, respectively (Smith, 2003;
Cello, 2002; Tian, 2004; Kodumal, 2004). In doing so they have showcased some of the
ambitious research goals which can take advantage of this synthetic capacity. Yet despite their
successes, they also underscore a severe need for DNA error reduction. Both the Venter and
Church teams found it necessary to purify their oligonucleotides prior to assembly. In the former
case this was a gel-based size separation needed prior to ligation (2 days added to the process).
In the latter case a series of selective hybridization selections (1.25 days) was crucial to
providing synthetic DNA of acceptable quality, as the oligonucleotides were synthesized in situ
on microarrays, and were of lower purity than oligonucleotides from a conventional vendor.
However, this procedure required the synthesis of an additional 200% more oligonucleotides to
be used as the selective agents. Each of these teams was able to produce a DNA construct of
fairly high quality, but in three cases only by first cloning and sequencing intermediate segments
followed by later steps of assembly, cloning, and sequencing the full length product. In the
remaining report, functional clones were achieved by natural selection in a manner reminiscent
of Stemmer et al.: the full length product was a bacteriophage genome-most failure products
could thus not replicate in a bacterial host. Even with this advantage (an estimated 20,000x
enrichment over the 'fatal' failures), a substantial number of non-lethal mutations were present in
the final sequenced products. This latter approach, while potent, will not generally be applicable
to the majority of desired gene synthesis targets, which will not encode reproducing systems.
To optimize among the many choices required in gene synthesis, we first made a careful
survey of the literature, chose initial protocols which showed the most promise for high
throughput gene synthesis, and set about testing and optimizing these procedures.
The first substantial choice is whether the initial gene construction is performed with 1)
DNA polymerase (i.e. PCA, polymerase construction and amplification, a general version is
shown in Figure 1; also called polymerase cycling assembly) or 2) DNA ligase. In both cases, a
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second step is required after the first assembly in order to amplify the desired full length gene,
typically by standard PCR. However, recent work by Tian et al. demonstrated that with PCA,
one may combine the two steps into a single reaction, where assembly predominates in the early
cycles, and amplification dominates the late cycles (see Figure 3 for our simulations of this
combined process). Consolidation of assembly and amplification is particularly attractive in the
context of minimizing processing steps for high throughput production. This would not be
possible with a ligase-based protocol, as polymerase extension products would frequently
terminate at the wrong 3' position of the strand for effective ligation to other oligos.
Purification of oligos prior to assembly is certainly one route towards minimizing errors
in gene synthesis. It can be argued that the amount of effort required for this type of error
reduction is commensurate with those we discuss below. However there are important
differences that require an understanding of the errors implicit in gene synthesis. The prominent
error in conventional oligo synthesis is a single base deletion, caused by a failure to couple a
particular base to the growing oligonucleotide chain. Most of these errors are "caught" by
capping the end of the chain with an acetyl group, resulting in a termination of chain growth, i.e.
a 5' truncation of the oligo. This is actually a very acceptable consequence for gene synthesis, as
the truncation represents a small amount of missing information, which is supplied by other full
length oligos in the assembly mixture. Assembly by polymerase or ligation approaches typically
yields a mixture of assembly products anyway, with incomplete strands effectively diluted out by
subsequent PCR amplification. Thus, while stepwise yields for oligo synthesis are typically
reported around 99% (i.e. a 1% failure rate per coupling step, a highly optimized organic
synthesis process) the majority of these errors are not propagated and the final synthetic genes
can have per base error rates of 1 in 500 or better using unpurified oligos. We have observed this
effect in our own gene syntheses, and similar results have been reported by others. Of greater
concern for gene synthesis errors are internal deletions (most often a single base deletion) which
can be the result of a failure to deprotect or combined failure to couple and failure to acetyl cap.
These single base deletions (length n-1, where n is typically 40 to 50 for gene synthesis) are
much harder to purify away from the full length product than the capped, truncated species
described above. Also, bases damaged from exposure to the chemical conditions of oligo
synthesis (e.g. depurination) can also give rise to errors in synthetic genes. Thus, optimization of
oligo synthesis chemistry for the specific purpose of gene synthesis seems likely to yield more
promising results than oligo purification.
Oligonucleotides can be purified collectively or individually, by high performance liquid
chromatography (HPLC) or polyacrylamide gel electrophoresis (PAGE). Individual purification
of each oligo (typically 20 or more) becomes impractical regardless of the method, and HPLC
will generally give poor resolution if samples are pooled. Both HPLC and PAGE are more effort
intensive than desired in an efficient, economical process. Thus, a purchased oligo that might
normally cost $10 becomes a $50 expense if extra purification is desired (IDT, current pricing
for 100 nmole scale synthesis).
Finally, all pre-assembly purification steps will not eliminate sufficient errors from the
final product, since errors can be introduced during the assembly and amplification processes,
such as from dNTP misincorporation by DNA polymerases. A pre-purification step may
perform well in synergy with error reduction later in the process, but a sufficiently effective late
stage treatment may make earlier purifications unnecessary.
The nature of the gene parse is also impacted by the choice of assembly protocol. The
desired full length sequence is used to determine which oligos must be synthesized in order to
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build the gene. 'Naive' parses have had some notable successes, simply chopping the sequence
up into overlapping 40-mers or 50-mers (Stemmer, 1995). However more advanced software is
now available to parse sequences with such considerations as normalizing melting temperatures,
optimizing codon usage, avoiding undesirable oligo properties (such as hairpin and primer-dimer
formation), and avoiding mispriming events that can lead to aberrations in the assembled gene.
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Figure 3. Simulation of a combined gene assembly and amplification reaction
employing 20 oligonucleotides. Blue squares indicate the concentration of the
amplifying oligonucleotide primer. Yellow triangles show the concentration of
final full length product. Other curves represent intermediates in the assembly
process. (Values are comparable to those observed in our gene assembly
experiments.)
Thus far we have synthesized
roughly two dozen genes of use to us in
various research projects, and assisted
colleagues in the synthesis of dozens
more. These have ranged in size from 300
bp to 3.2 kb. More important for our
purposes than the number or sizes of genes
we make is the ability to easily evaluate
success or failure of a given approach to
gene synthesis or error reduction. Two
particular targets we have synthesized
repeatedly in different ways are gene
constructs with straightforward readout:
LacZ (blue/white screening, i.e. colony
counts) and Green Fluorescent Protein
(GFP, assessed by colony counts and flow
cytometry, see Figures 7 and 13
respectively). These have been extremely
useful to us in comparing a wide variety of
experimental variables. In many cases
these have been used to decide which
datasets are worth examining further by
DNA sequencing (>300,000 bp sequenced
thus far).
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Figure 4. Error removal for green fluorescent
protein (GFP) gene synthesis. Two different petrie
dishes are shown (half of each). Left: E. coli cells
expressing genes which have been treated by the
method of Figure 12 to remove errors (>90%
fluorescent, brighter colonies). Right: cells
expressing the flawed genes extracted in the same
process (<10% fluorescent). Not shown: untreated
cells (-40% fluorescent). Images aqcuired in
grayscale, and color-enhanced (all images
enhanced with exactly the same parameters).
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Figure 6. Choice of a high-fidelity
proofreading polymerase (such as Pfu
Turbo or Phusion) is important in for
reducing gene synthesis error rates. Data
acquired from synthesis of a GFP gene
construct from a pool of 50-mer
oligonucleotides, employing various PCR
polymerases, and assayed by flow
cytometry.
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Our most common basis
set for these experiments has
been a pool of forty 50-mer
oligonucleotides used to
assemble the GFP construct,
using a two PCR assembly
reaction, with the high-fidelity
polymerase Pfu Turbo Hotstart
(Stratagene). The parse for this
set is 'naive' in that the
sequences nave not been
optimized in any way, despite
known possible sites for
misassembly in our construct.
Thus errors that may be due to
the parse can be revealed, and we
can observe if our error reduction
protocols are able to handle these
errors. (We have detected a 50 bt)
deletion caused by a mispriming event,
recurring at low frequency.) The construct is
cloned using the Gateway cloning system
(Invitrogen), with no cloning errors observed in
over 200 clones sequenced. Error rates for this
basis set were measured by sequencing to be
1.8x10-3 per base pair synthesized. Flow
cytometry analysis of this set leaves us with a
dynamic range of measurement for error rates
which are both higher and lower than this
figure. Even our evaluation of simple choices
for gene synthesis has been informative. Among
other parameters, we have examined the
influence of oligo vendor (Figure 5), DNA
polymerase (Figure 6), and oligo length (Figure
7).
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We were surprised by the large
impact of oligo vendor. Each of these
reputable companies produces oligos
very satisfactory for most applications,
and can provide standard measures of
quality control (e.g. mass spectroscopy,
analytical HPLC). However, since the
errors that survive PCA gene synthesis
are only a minority of the total, these
lower frequency errors are not readily
apparent, nor are they a concern to
most users. This observation further
underscores the potential for
optimization of oligo synthesis
chemistry to improve the quality of
synthetic genes. Oligo length was
expected to have some impact, as
longer oligos have been subjected to
more cycles of harsh chemical
exposure. Thus in addition to the stepwise yield reported per base coupling, an additional source
of error seems a function of overall exposure. This influence is important to grasp: many users
otherwise prefer to use longer oligos when possible, leaving longer single stranded gaps in the
overall gene parse as a way of saving on costs of oligo synthesis. Third, the consequence of PCR
polymerase is dramatic-a high-fidelity proofreading polymerase is essential. Taq polymerase,
with a known high error rate for DNA synthesis, was expected to perform poorly. Still many
users have attempted to build genes with this enzyme, or with blends of Taq and a proofreading
polymerase, with only a moderate improvement in fidelity over Taq polymerase by itself. We
expected a larger contribution from oligo synthesis errors would mostly mask observable
differences between a high-fidelity polymerase (Pfu Turbo, Stratagene) and one of the new "ultra
high-fidelity" enzymes (such as Phusion from Finnzymes, Pfu UltraII from Stratagene, or Pfx5O
from Invitrogen). Still, we found a roughly two-fold difference in synthetic gene errors between
these two categories, indicating that the polymerases may be contributing more errors than
initially expected. However, in this case our interpretation of the flow cytometry data will need
to be followed up with further sequencing, as the proportion of silent errors could be different
between these polymerases. Despite their impact, we have not seen any of the above factors
reported substantially in the literature.
Error Correction for Gene Fabrication
The optimizations from the above gene fabrication may be able to reduce the error rates
in gene synthesis, but we do not expect them to yield error rates lower than perhaps 0.0005 per
base. Especially in the cases of assembling long DNA constructs, or of reliably assembling large
numbers of high-fidelity genes in parallel, further error reduction will be required (See Figure 2).
What are the properties of our ideal error reduction system? It should be:
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Figure 7. Effect of oligonucleotide length on gene
synthesis error rate. Oligonucleotides of various
lengths were purchased from MWG-Biotech and
assembled into gene constructs capable of expressing
GFP. Clones were assayed by flow cytometry.
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1. Capable of handling all major types of errors
2. Rapid to perform
3. Need only be performed once (or be easy to iterate)
4. Simple to implement into an automated system
The following error correction involving the use of the mismatch recognition protein
MutS was chosen as our most likely candidate for attaining a broadly applicable error reduction
system by Dr. Peter Carr and Jason Park several years ago. Initial studies focused on criteria 1,
an essential step before optimizing criteria 2-4. Commercial sources were available for MutS
from E. coli ("Eco MutS," USB) and T. aquaticus ("Taq MutS," Epicentre). Principal concerns
were the specificity of MutS proteins, specifically a relatively high degree of nonspecific DNA
binding (i.e. in the absence of mismatches) and poor binding to CC mismatches in
the cane of the E cnli nrmtein (Brown 354). The Tao
MutS protein had been previously observed to not
have CC binding deficiency. Since then, I have
helped work on improving gel filtration error
correction through the use of higher fidelity MutS
proteins as well as optimizing incubation times of the
MutS protein with the error-containing DNA. I will
r _. a s . t -t _1.: : _irst aescribe tne gel nitration error correction and
then move onto a discussion of the new proteins and
new error correction methods we have developed
since the original gel filtration paper published by
Carr et al. in 2004.
Both proteins ("Taq MutS" and "Eco MutS")
were tested in simple gel mobility shift assays as
employed in the literature, assaying binding to
different types of single base mismatches constructed
from oligonucleotide duplexes. Taq MutS proved
more reliable in these studies, though initial binding
tests with some types of mismatches appeared
discouraging. We demonstrated that Taq MutS was
capable of binding well to a single base deletion
mismatch, and separating these complexes from those
without mismatches. In a small sample, cloning and
sequencing of these constructs confirmed that the
micmnatrhpe ha han rmnved 1n lnnpe ananlv7.ed
no mismatches present from an initial 50/50 mixture).
Given that single base deletions are the dominant error we have observed in gene
synthesis, we used this procedure to separate mismatches from a pool of synthetic fragments
used to build our -Ikb GFP gene construct (see Figure 9). Early attempts to perform this
procedure with the full length construct gave results which proved difficult to reproduce, thus
smaller fragments were used. (Note: this was indeed a length-dependent effect. At the same per
base error rate, longer DNA is more likely to contain a mismatch and thus bind MutS, leaving
behind a smaller unbound fraction.
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Figure 8. Polyacrylamide gel
electrophoresis (PAGE) of DNA
segments used to assemble the GFP
gene construct. Lane 1: size standard
(kb DNA Ladder, Stratagene; from
bottom, sizes are 250, 500, 750, and
1000 bp). Lanes 2-5: the four segments,
each complexed with MutS. Lower
bands are the error-depleted fractions;
upper bands are the error-enriched
(MutS-bound) fractions. Lanes 6-9: the
same four segments, with no MutS
present. Some smearing of the DNA is
consistently observed between the two
bands in all lanes containing MutS,
likely representing protein-DNA
complexes which have dissociated.
Figure 9. Construction of synthetic genes employing MutS
protein for error-reduction. The pie chart indicates the
approximate amount of time consumed by each step (in
hours), with a red arrow indicating the order of operations.
The most time consuming steps in this process are often
oligonucleotide synthesis and DNA sequencing (including
plasmid production). The 24+ and 48+ hours indicated for
each of these represent lower bounds on these processes,
possible if performed with immediate access to the appropriate
equipment. If these steps are performed by outside providers,
3-5 days are typical of each step. Box 1: gene segments are
synthesized and amplified using conventional PCR protocols.
The resulting products are dissociated and re-annealed so that
errors are present as DNA heteroduplexes (mismatches). Box
2: MutS protein is mixed with this pool of molecules and
binds to mismatches. The error-enriched (MutS-bound)
fraction is resolved from the error-depleted fraction by
electrophoresis. Box 3: The error-depleted segments are
assembled into the desired gene and amplified by PCR prior to
cloning.
We have since optimized this
procedure so that it works
quite well with 1 kb genes).
The overall process used for
error removal and assembly is
diagrammed in Figure 9.
Competent cells were
transformed with vector
(pDONR221) carrying the
synthetic GFP genes, and both
plated (for colony counts,
Figure 4), and analyzed by
flow cytometry. Various sets
of data were analyzed from
this procedure, including DNA
that was put through the error
removal process a second time
(this time as the assembled 1
kb construct) and products
built from the fragments that
were specifically bound by
MutS (i.e. an error-enriched
pool).
Approximately 40
clones were sequenced from
each of four sets: error-
enriched, untreated, error-
depleted, and error-depleted
twice. A strong trend was
evident for error removal by
this MutS procedure, including
a highly error-enriched pool
from the MutS-bound fraction.
All categories of errors first
observed in the untreated pool
were substantially diminished
with each cycle of error
reduction.
The first cycle
of error removal
reduced the overall
error rate 6.9-fold, to
0.00026 per base. The following cycle reduced this figure a further 2.6-fold, to 0.00010
per base. No other approach has achieved such an effective result applicable to general
gene synthesis without first cloning and sequencing fragments, followed by subsequent
assembly steps and later rounds of cloning and sequencing. To demonstrate the
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usefulness of this method, we applied a single cycle of error depletion to the construction
of our own Taq MutS gene (2.5kb), sent a single clone for sequencing, and found it to
contain the correct product (an estimated 50% likelihood). In the absence of error
removal, we would expect to sequence -100 clones to reliably achieve this result (Figure
2). We now express and purify our own supplies of Taq MutS protein, which we have
used in our technique to produce other genes of comparable size. For these constructs,
we typically sequence 3 clones and find one or more to be correct.
II. Current and Future Work
New Proteins Synthesized for potential use in Error Correction
In the interests of devising improved methods for DNA error reduction, we have designed
and synthesized the genes for several new proteins, some of which have been only minimally
studied in the literature. These include new species of MutS, intended for optimization of our
current methods. Others possess new functions. Proteins that have a potential role in mismatch
biding or mismatch cleavage are of particular interest. Often initial reports exist where such
proteins have been characterized for a related purpose: mismatch detection for analysis of
genetic variation. In principle, functions which detect mismatches also have potential for error
elimination as well. An important difference, however, is that for detection often only a small
fraction of a sample need be bound or cleaved, whereas for error elimination the entire sample
must be processed thoroughly. Thus if a putative mismatch nuclease cleaves very inefficiently, it
may still serve well for mutation detection but not overall error correction.
The likelihood of any new protein being superior to MutS for error reduction is difficult
to assess. Certainly, the effort to obtain these proteins carries with it some risk. However, it is
precisely our capacity to synthesize genes quickly and easily that makes the cost of taking such
risks relatively small. Some of them have truly been "genes of convenience" i.e. when we have
required a new or different gene to test an assembly method, we have selected one from our wish
list. Protein production is typically with established T7 expression systems in E. coli.
Purification is generally aided by protease-cleavable polyhistidine tags and by the thermostable
properties many of these proteins possess. Table I presents many of the proteins we have
produced thus far, several of which are in the early testing phase or are about to be tested.
Table I. Proteins produced for error reduction. Those protein features which have gone through
at least an initial screen for function have that feature or use shown in bold face.
Protein Source Organism Modifications Expressed? Purified? Thermostability Putative Uses
predicted measured
MutS-FokIN E. coli his-tag, Y insoluble no mismatch
F.okeanokoites protein fusion endonuclease
MutS T. aquaticus his-tag Y Y >60 C 75 C MutS gel, columns
MutS T. maritima his-tag, Y Y >75 C 82 C MutS gel, columns
linker
MutS(K620M) T. maritima his-tag, Y Y >75 C error-correcting
linker, PCR
-ATPase
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MutS A. aeolicus his-tag Y Y >90 C >95 C MutS gel,
linker columns
MutS(K620M) A. aeolicus his-tag, Y Y >90 C error-correcting
linker, PCR
-ATPase
Hjc SIRV-I his-tag Y in progress >70 C mismatch
endonuclease
EndoV T. Thermophilus his-tag Y Y >60 C >60 C mismatch
endonuclease
SSB S. solfataricus his-tag Y Y >70 C mismatch binding
Tools to Characterize our Proteins
In attempting to characterize all of our proteins used in our research, we have identified
two instruments for use. We are currently finishing up the characterization of all of our proteins
through the employment of both of these measurement tools and are in the final stages of our
data analysis. We plan to publish our results soon of our analysis of the various proteins we have
built and used in our error correction protocols over the years.
Circular dichroism (CD) spectroscopy measures differences in the absorption of left-
handed polarized light versus right-handed polarized light which arise due to structural
asymmetry. The absence of regular structure results in zero CD intensity, while an ordered
structure results in a spectrum which can contain both positive and negative signals (APL). We
are using this tool to test the DNA and MutS interaction through various temperatures (ranging
from room temperature to 95 degrees Celsius) and for various wavelengths (from 220nm to
320nm).
Figure 10. The Olympus Evotech MF20. The only system in
the United States is in the Zhang Lab at 500 Technology Square.
Professor Jacobson's Biology Lab work is all done in the Zhang
Lab space.
The Olympus Evotec MF20 system is a useful tool that employs a technique known as
single molecular fluorescence spectroscopy that does not require the sample to be in a solid
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phase. Instead, interactions between biological molecules can be studied directly in buffer
solution. High-speed analysis yields data on functional biomolecular interactions and binding
within a short period of time ranging from a few seconds to less than a minute. A combination
of confocal laser optical system with a high-sensitivity fluorescence detection device permits
measurements in an extremely small volume of around 1 femtoliter (1 fL = 1 x 10-15 L), thereby
capturing any interactions at the level of single molecules. This set-up operates at low noise and
detects fluorescent signals with extremely high sensitivity. In addition, since measurements are
performed in solution, damage to the sample is minimal and artifacts from unspecific surface
interaction are avoided. This allows the same sample to be rapidly put through other tests
subsequently. We have designed an oligonucleotide sequence with a fluorescent tag on one end
which can be picked up by the MF20.
Through our characterization and tests, we have found one of our new strains of MutS
(Aae) to give us higher fidelity in error correction and to work better over a wider range of
temperatures.
Methods in Error Correction
MutS has been used as our primary tool for error correction. We have built and tested
several different strains of the MutS protein. Below, I will elaborate on some protocols proposed
by Jason Park (MIT '05) in his thesis since which we have done a lot more work on.
MutS pull-down - As described in Jason Park's 2A thesis, MutS pull-down is a protocol in which
newly synthesized DNA product (or fragments thereof, in the case of gene targets too large for
this procedure) are melted and re-annealed to re-assort errors and create heterodimers of errors as
described earlier. In this protocol, the DNA is then exposed to MutS (T. aquaticus) under a
certain set of reaction conditions (temperature, time, etc.) at which point DNA with errors is
selectively bound by the MutS.
Figure 11 shows a TBE non-
denaturing polyacrylamide gel
showing the difference of running
DNA alone and DNA with MutS. A
shifted band of DNA bound to MutS
can be seen, due to the reduced
mobility of the complex relative to
unbound DNA. After performing a
AA-t. ngl7_Hnu n Va PnPriP thn
Figure 11 MutS pull-down filter. Lane 1: kb ladder. Lanes Wu4&,"L ---VI. L wJ
2,3,4,5: -300mer pieces of GFP (993bp), treated with MutS. Lanes error-depleted DNA by using the
6,7,8,9: Same as lanes 2,3,4,5, except without MutS treatment. crush and soak method and then use
(From Carr et al., 2004) PCR to amplify this "good DNA."
Since the Carr et al. paper was
published, I have been helping test the efficacy of our other MutS proteins (the A. aeolicus and
the T. thermophilus). Initial tests have shown the A. aeolicus protein to give us better efficacy
and than the T. aquaticus. The T. thermophilus MutS protein had only a slightly better efficacy
in error binding than the T. aquaticus. In our protein characterization that we plan to submit for
review in a month or so we will quantify these differences in protein efficacy.
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MutS-Foklfusion - The major design component of my 2A thesis involves the design of the
MutS-Foklfusion design. I have worked with Dr. Carr and Jason Park to design and build this
fusion protein. MutS (Figure 12) as previously mentioned is a protein that binds to
heteroduplexes in DNA. FokI (Figure 13) is a member of the type IIS "outside cutter" class of
endonucleases, which bind to a specific DNA sequence but cleave at a remote site (Modrich,
1991). The original goal of the MutS-Foklfusion was to have the protein bind to the error and
then cleave around the error after which we could separate the two pieces. The original design
that Jason Park proposed in his 2A thesis had some major problems. I have been helping to
design a new and improved version of MutS-Foklfusion composed of fusing the FokI nuclease
domain to the N-terminus of the Aquifex aeolicus MutS via a flexible and soluble (Gly-Ser-Gly)n
linker of variable-length. We have decided to use the ATPase-deficient mutant version of the
Aquifex aeolicus MutS as it is the most thermostable of the MutS protein variants we have
synthesized in our lab.
We have decided to express the fusion protein in a plasmid vector system such as pET-
32, pET-41, pET-42, pET-43.1, or pET-44. These vectors fuse a protein such as thioredoxin,
NusA, or GST to the protein of interest for enhanced production and solubility. A (His)6 tag,
which will be used in protein purification, is also included. These proteins can later be cleaved
off at a known site after expression and purification. Improved solubility is an important
consideration in building the MutS-FokIN fusion construct, especially since the earlier version of
the protein was shown to be insoluble.
We have decided to take a modular approach to building the MutS-FokIN fusion
construct in order to facilitate the making of versions of the construct with different length
linkers. By minimizing the amount of necessary PCR and sequencing, we can cut down on time
and cost expended.
We have also decided to attach flanking sequences to the 5' and 3' ends of the existing
MutS and FokIN DNA constructs to insert appropriate restriction sites. These constructs will be
ligated sequentially into a plasmid vector after restriction endonuclease digestion. Clones will be
screened and sequenced at this point. After verifying that the desired construct has been made
successfully, the (Gly-Ser-Gly)n linkers of various lengths - which will have been made with
appropriate sticky ends by annealing synthesized oligonucleotides - will be ligated into the new
plasmid construct. After one more round of screening and sequencing clones, we will proceed
with protein purification and expression.
Now that the design is complete we hope to build and test the MutS-Foklfusion protein in
the next several weeks.
Figure 12 MutS (Sixma, 2001)
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Figure 13 FokI nuclease (Wah et al., 1997)
MSPCR - MutS-in-PCR (MSPCR) is a novel idea for error prevention that involves the use of
the MutS protein in the gene fabrication PCR reaction that was originally proposed by Jason
Park in his 2A thesis. The main idea behind MSPCR is to address errors before they become
integrated into synthesized DNA. Originally in his thesis, Jason Park outlines the idea of using
thermostable T. aquaticus MutS for use in this protocol (Park, 2005). However, initial tests of
the Taq MutS in PCR did not prove to be very effective. After some tests we found that Taq
becomes denatured in the low 80 degrees Celsius. This is where our new hyper-thermophilic
MutS proteins have been extremely effective and useful. Especially our A. aeolicus MutS
protein has been effective up to mid 90 degrees Celsius without denaturation. Aae also seems to
bind better to DNA mismatches than our other MutS proteins.
I PCR >
Figure 14 One proposed mechanism of action of MutS in MSPCR - Steric
blocking of polymerase for short pieces of DNA and for mismatches near 3'
ends (* denotes error)
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Figure 15 Another proposed mechanism of
action of MutS in MSPCR - MutS binds error;
polymerase copies everywhere but mismatch
(falls off once it reaches MutS)
All of the abovementioned protocols are error correction/reduction/prevention protocols
developed as a result of the work of Dr. Peter Carr, Jason Park, myself, and Professor Joseph
Jacobson. We will be continuing to work to perfect our current methods as well as to design new
protocols in the future.
III. Closing Statement
Continued improvement in error-correction methods is pivotal in furthering the field of
biological engineering and more specifically in the field of gene fabrication. A good error
correction protocol should be a quick, easy, robust, economical, and effective method by which
errors in a gene product synthesized in gene fabrication is reduced (Park, 2005). Some of the
protocols and methods mentioned above are effective tools to accomplish error
correction/reduction while others are still very much a "work in progress."
In the future, I plan on finishing up the projects that I have mentioned in the "current and
future work" section that are yet perfected over the summer and as a Masters Degree student next
year. The development of error correction and prevention protocols and methods involves
engineering optimization and design, as well as a solid background and understanding of
biological processes and systems and my mechanical engineering background has been
invaluable in our research.
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